Vertex Pharmaceuticals (VRTX)
(Real Time Quote from BATS)
$470.32 USD
+2.32 (0.50%)
Updated Sep 9, 2024 03:02 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/4/24 |
---|---|
Current Quarter | 4.11 |
EPS Last Quarter | -12.83 |
Last EPS Surprise | -11.57% |
ABR | 1.87 |
Earnings ESP
|
-2.80% |
---|---|
Current Year | 0.36 |
Next Year | 18.03 |
EPS (TTM) | 0.21 |
P/E (F1) | 1,318.31 |
% EPS Growth Estimates | VRTX | IND | S&P |
---|---|---|---|
Current Qtr (09/2024) | 0.74 | 159.79 | 11.23 |
Next Qtr (12/2024) | -2.38 | 111.90 | 20.57 |
Current Year (12/2024) | -97.64 | 17.50 | 15.67 |
Next Year (12/2025) | 4,908.33 | 9.40 | 11.34 |
Past 5 Years | 38.20 | 0.90 | 8.10 |
Next 5 Years | 12.50 | 21.70 | NA |
PE | 1,318.31 | -6.40 | 21.90 |
PEG Ratio | 105.46 | -0.29 | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.68B | 2.73B | 10.74B | 11.80B |
# of Estimates | 11 | 11 | 10 | 11 |
High Estimate | 2.73B | 2.81B | 10.87B | 13.73B |
Low Estimate | 2.64B | 2.65B | 10.65B | 11.14B |
Year ago Sales | 2.48B | 2.52B | 9.87B | 10.74B |
Year over Year Growth Est. | 7.83% | 8.39% | 8.87% | 9.85% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 4.11 | 4.10 | 0.36 | 18.03 |
# of Estimates | 12 | 10 | 12 | 11 |
Most Recent Consensus | 3.91 | 4.08 | -0.08 | 17.32 |
High Estimate | 4.90 | 4.81 | 3.75 | 21.69 |
Low Estimate | 3.80 | 3.48 | -0.32 | 15.03 |
Year ago EPS | 4.08 | 4.20 | 15.23 | 0.36 |
Year over Year Growth Est. | 0.74% | -2.38% | -97.64% | 4,910.00% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 1 | 0 | 0 |
Up Last 60 Days | 5 | 3 | 0 | 8 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 1 | 1 |
Down Last 60 Days | 5 | 5 | 12 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 4.11 | 4.10 | 0.36 | 18.03 |
7 Days Ago | 4.11 | 4.10 | 0.36 | 18.03 |
30 Days Ago | 4.11 | 4.10 | 1.76 | 18.04 |
60 Days Ago | 4.02 | 4.02 | 17.06 | 17.27 |
90 Days Ago | 4.02 | 4.02 | 17.06 | 17.27 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 3.99 | 4.08 | -0.02 | 17.68 |
Zacks Consensus Estimate | 4.11 | 4.10 | 0.36 | 18.03 |
Earnings ESP | -2.80% | -0.51% | -104.23% | -1.97% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -12.83 | 4.76 | 4.20 | 4.08 | NA |
Estimate | -11.50 | 4.10 | 4.10 | 3.92 | NA |
Difference | -1.33 | 0.66 | 0.10 | 0.16 | -0.10 |
Surprise | -11.57% | 16.10% | 2.44% | 4.08% | 2.76% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more